The abstract is read at the publisher; the summary is JClub's.
In a nested case-control study of Kenyan transactional-sex women, BV, high vaginal diversity, and CST III/IV are linked to incident Chlamydia trachomatis, with mediation by vaginal metabolites.
- Why it matters: BV is a major risk factor for CT, but how BV-associated bacteria translate into infection susceptibility is unclear; metabolite-mediated mechanisms could guide interventions.
- What they did: Using qPCR for CT and total bacterial load, 16S rRNA sequencing for microbiome, and Nugent-Hillier/Amsel BV scoring, the study compared pre-CT samples; targeted LC-MS measured metabolites in a subset.
- The result: Concentrations and relative abundances of Lactobacillus crispatus and BV-associated bacteria predicted CT outcomes, pre-CT metabolites (including Tyramine, reduced/oxidized Glutathione, and sucrose) differed, and mediation analysis showed the vaginal metabolome significantly mediated the microbiome–CT relationship.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.